Abstract
Background Capsule endoscopy is a relatively new imaging tool for the detection of small bowel pathology. The assessment of the severity of Crohn’s disease by capsule endoscopy is not standardized and is limited by interobserver variations in interpreting the findings. Aim To develop, assess and validate a new, simple capsule endoscopy Crohn’s disease activity index (CECDAI) in order to grade the severity of small bowel capsule endoscopy findings. Methods The system involves dividing the small bowel into proximal and distal segments according to transit time and then rating each segment on the basis of three parameters: inflammation (A), extent of disease (B) and presence of strictures (C). The segmental score is calculated by multiplying the inflammation subscore by the disease-subextent score and adding the stricture subscore (A × B + C); the final score is calculated by adding the two segmental scores: CECDAI = (A1 × B1 + C1) + (A2 × B2 + C2). In the present study, four senior endoscopists (two with experience in capsule endoscopy interpretation) independently reviewed coded capsule endoscopy videos of 20 patients with Crohn’s disease and rated them according to the CECDAI. Interobserver variability was analyzed by Spearman’s correlation test. Results The CECDAI total scores for the 20 patients ranged from 0 to 26. The correlation for the total score assigned between every two observers was 0.867 (0.700−1.000 = strong degree association; WHO classification; P < 0.0001). The Kappa statistics for agreement among all observers for the subscores and total scores were as follows: A1, 0.31 ± 0.05; B1, 0.25 ± 0.05; C1 (no cases); A2, 0.51 ± 0.05; B2, 0.57 ± 0.05; C2, 0.27 ± 0.07. All examiners reported that the system was simple to learn and apply. Conclusions The CECDAI score may serve as a convenient, reliable and reproducible diagnostic and follow-up tool for use by experienced endoscopists in the evaluation of patients with Crohn’s disease of the small bowel.
Similar content being viewed by others
References
Marmo R, Rotondano G, Piscopo R et al (2005) Capsule endoscopy versus enteroclysis in the detection of small-bowel involvement in Crohn’s disease: a prospective trial. Clin Gastroenterol Hepatol 3:772–776
Voderholzer WA, Beinhoelzl J, Rogalla P et al (2005) Small bowel involvement in Crohn’s disease: a prospective comparison of wireless capsule endoscopy and computed tomography enteroclysis. Gut 54:369–373
Eliakim R, Fischer D, Suissa A et al (2003) Wireless capsule video endoscopy is a superior diagnostic tool in comparison to barium follow-through and computerized tomography in patients with suspected Crohn’s disease. Eur J Gastroenterol Hepatol 15:363–367
Triester SL, Leighton JA, Leontiadis GI et al (2005) A meta-analysis of the yield of capsule endoscopy compared to other diagnostic modalities in patients with obscure gastrointestinal bleeding. Am J Gastroenterol 100:2407–2418
Mary JY, Modigliani R (1989) Development and validation of an endoscopic index of the severity for Crohn’s disease: a prospective multicentre study. Groupe d’Etudes Therapeutiques des Affections Inflammatoires du Tube Digestif (GETAID). Gut 30:983–989
Daperno M, D’Haens G, Van Assche G et al (2004) Development and validation of a new, simplified endoscopic activity score for Crohn’s disease: the SES-CD. Gastrointest Endosc 60:505–512
Pera A, Bellando P, Caldera D et al (1987) Colonoscopy in inflammatory bowel disease. Diagnostic accuracy and proposal of an endoscopic score. Gastroenterology 92:181–185
D’Haens G (2004) Mucosal healing in pediatric Crohn’s disease: the goal of medical treatment. Inflamm Bowel Dis 10:479–480
Modigliani R, Mary JY, Simon JF et al (1990) Clinical, biological, and endoscopic picture of attacks of Crohn’s disease. Evolution on prednisolone. Groupe d’Etude Therapeutique des Affections Inflammatoires Digestives. Gastroenterology 98:811–818
D’Haens G, Geboes K, Rutgeerts P (1999) Endoscopic and histologic healing of Crohn’s ileocolitis with azathioprine. Gastrointest Endosc 50:667–671
Rutgeerts P, Diamond RH, Bala M et al (2006) Scheduled maintenance treatment with infliximab is superior to episodic treatment for the healing of mucosal ulceration associated with Crohn’s disease. Gastrointest Endosc 63:433–442
Geboes K, Rutgeerts P, Opdenakker G et al (2005) Endoscopic and histologic evidence of persistent mucosal healing and correlation with clinical improvement following sustained infliximab treatment for Crohn’s disease. Curr Med Res Opin 21:1741–1754
Cellier C, Sahmoud T, Froguel E et al (1994) Correlations between clinical activity, endoscopic severity, and biological parameters in colonic or ileocolonic Crohn’s disease. A prospective multicentre study of 121 cases. The Groupe d’Etudes Therapeutiques des Affections Inflammatoires Digestives. Gut 35:231–235
Sandborn W, Feagan B, Hanauer S et al (2002) A review of activity indices and efficacy endpoints for clinical trials of medical therapy in adults with Crohn’s disease. Gastroenterology 122:512–530
Naber A, de Jong D (2003) Assessment of disease activity in inflammatory bowel disease; relevance for clinical trials. Neth J Med 61:105–110
Costamagna G, Shah S, Riccioni M et al (2002) A prospective trial comparing small bowel radiographs and video capsule endoscopy for suspected small bowel disease. Gastroenterology 123:999–1005
Goldstein JL, Eisen GM, Lewis B et al (2005) Video capsule endoscopy to prospectively assess small bowel injury with celecoxib, naproxen plus omeprazole, and placebo. Clin Gastroenterol Hepatol 3:133–141
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Gal, E., Geller, A., Fraser, G. et al. Assessment and Validation of the New Capsule Endoscopy Crohn’s Disease Activity Index (CECDAI). Dig Dis Sci 53, 1933–1937 (2008). https://doi.org/10.1007/s10620-007-0084-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10620-007-0084-y